# OnCo record immunoah (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/immunoah/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "immunoah" ;
  schema:name "Beijing Immunoah Pharma Tech"@en ;
  schema:alternateName "Immunoah"@en, "Beijing Immune Ark Medical Technology"@en, "Beijng Immunoah Pharma Tech Co., Ltd."@en ;
  schema:description "Beijing Immunoah develops antibodies that switch on the immune system against cancer, including antibodies that bind two or three targets at once. Its first registered study tests an injection given directly into tumours in advanced solid cancers."@en ;
  schema:url <https://onco.cc/companies/immunoah/>, <http://www.immunoah.cn/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <http://www.immunoah.cn/>, <http://en.immunoah.cn/aboutus1.html>, <https://clinicaltrials.gov/study/NCT06292858> ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:targets <https://onco.cc/targets/cd137/>, <https://onco.cc/targets/cd40/>, <https://onco.cc/targets/tnfrsf4/> .